Difference between revisions of "Part:BBa K1469001:Experience"

Line 3: Line 3:
 
Part is user sequenced: no illegal restriction sites and no mutations
 
Part is user sequenced: no illegal restriction sites and no mutations
  
Protein expression was checked by SDS-PAGE and Western Blot.[http://2014.igem.org/Team:Saarland/4_step]
+
Protein expression was checked by SDS-PAGE and Western Blot.[http://2014.igem.org/Team:Saarland/4_step#WesternBlot]
  
 
Localisation of a GFP tagged Has2 protein variant was checked by fluorescence microscopy.[http://2014.igem.org/Team:Saarland/4_step]
 
Localisation of a GFP tagged Has2 protein variant was checked by fluorescence microscopy.[http://2014.igem.org/Team:Saarland/4_step]

Revision as of 13:32, 15 October 2014


Part is user sequenced: no illegal restriction sites and no mutations

Protein expression was checked by SDS-PAGE and Western Blot.[http://2014.igem.org/Team:Saarland/4_step#WesternBlot]

Localisation of a GFP tagged Has2 protein variant was checked by fluorescence microscopy.[http://2014.igem.org/Team:Saarland/4_step]

No catalytic activity probably due to misfolding and intracellular accumulation.[http://2014.igem.org/Team:Saarland/4_step]

Applications of BBa_K1469001

BioBrick is designed for production of high molecular mass hyaluronic acid (HMM-HA) in a Bacillus megaterium based expression system. HMM-HA is supposed to have inhibitory effects on cancer cell lines

User Reviews

UNIQ08e5e424461b43d9-partinfo-00000000-QINU UNIQ08e5e424461b43d9-partinfo-00000001-QINU